To provide the Food and Drug Administration with authority to conduct microbial sampling on concentrated animal feeding operations as necessary to facilitate a foodborne illness outbreak investigation, determine the root cause of an outbreak of foodborne illness, or address other public health needs.

Referred to the House Committee on Energy and Commerce.

Bill 119 HR 852, also known as the "Microbial Sampling of Concentrated Animal Feeding Operations Act," aims to grant the Food and Drug Administration (FDA) the power to conduct microbial sampling on concentrated animal feeding operations (CAFOs) when necessary for various public health reasons.

The primary purpose of this bill is to allow the FDA to collect samples from CAFOs in order to investigate foodborne illness outbreaks, identify the source of the outbreak, and address other public health concerns related to these operations. This authority would enable the FDA to better protect consumers from foodborne illnesses that may originate from CAFOs.

By granting the FDA the ability to conduct microbial sampling on CAFOs, this bill seeks to enhance the agency's ability to respond to and prevent foodborne illness outbreaks, ultimately safeguarding public health. This legislation does not aim to regulate CAFOs or impose additional restrictions on these operations, but rather to empower the FDA to take necessary actions to ensure the safety of the food supply.